Intravesical therapy in the management of superficial transitional cell carcinoma of the bladder: the experience of the EORTC GU Group
Open Access
- 1 April 1990
- journal article
- review article
- Published by Springer Nature in British Journal of Cancer
- Vol. 61 (4) , 497-499
- https://doi.org/10.1038/bjc.1990.112
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Mitomycin C in Superficial Bladder Cancer: 24‐month Follow‐upBritish Journal of Urology, 1985
- Adjuvant Chemotherapy of Superficial Transitional Cell Bladder Carcinoma:Preliminary Results of a European Organization for Research onTreatment of Cancer Randomized Trial Comparing Doxorubicin Hydrochloride, Ethoglucid and Transurethral Resection AloneJournal of Urology, 1984
- Does Intravesical Chemotherapy Prevent Invasive Bladder Cancer?Journal of Urology, 1984
- ANAPHYLACTIC REACTIONS TO REPEATED INTRAVESICAL INSTILLATION WITH CISPLATINThe Lancet, 1983
- Experience with Bacillus Calmette-Guerin in Patients with Superficial Bladder CarcinomaJournal of Urology, 1982
- Bacillus Calmette-guerin Immunotherapy of Superficial Bladder CancerJournal of Urology, 1980
- Single Dose Intravesical Thiotepa as an Adjuvant to Cystodiathermy in the Treatment of Transitional Cell Bladder CarcinomaBritish Journal of Urology, 1976
- Benign Papilloma or Papillary Carcinoma of the Bladder?Journal of Urology, 1973
- The management of superficial bladder tumours with intravesical Epodyl.1973